These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10439568)
41. The postoperative analgesic efficacy of preperitoneal continuous wound infusion compared to epidural continuous infusion with local anesthetics after colorectal cancer surgery: a randomized controlled multicenter study. Bertoglio S; Fabiani F; Negri PD; Corcione A; Merlo DF; Cafiero F; Esposito C; Belluco C; Pertile D; Amodio R; Mannucci M; Fontana V; Cicco MD; Zappi L Anesth Analg; 2012 Dec; 115(6):1442-50. PubMed ID: 23144438 [TBL] [Abstract][Full Text] [Related]
42. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. Viscusi ER; Reynolds L; Chung F; Atkinson LE; Khanna S JAMA; 2004 Mar; 291(11):1333-41. PubMed ID: 15026400 [TBL] [Abstract][Full Text] [Related]
43. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Bruera E; Brenneis C; Michaud M; Bacovsky R; Chadwick S; Emeno A; MacDonald N Cancer; 1988 Jul; 62(2):407-11. PubMed ID: 2454724 [TBL] [Abstract][Full Text] [Related]
44. The addition of epidural local anesthetic to systemic multimodal analgesia following lumbar spinal fusion: a randomized controlled trial. Choi S; Rampersaud YR; Chan VW; Persaud O; Koshkin A; Tumber P; Brull R Can J Anaesth; 2014 Apr; 61(4):330-9. PubMed ID: 24519631 [TBL] [Abstract][Full Text] [Related]
46. Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system. Hildebrand KR; Elsberry DE; Anderson VC J Pain Symptom Manage; 2001 Dec; 22(6):1042-7. PubMed ID: 11738167 [TBL] [Abstract][Full Text] [Related]
47. Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone. Shanthanna H; Paul J; Lovrics P; Vanniyasingam T; Devereaux PJ; Bhandari M; Thabane L Br J Anaesth; 2019 Jun; 122(6):e107-e113. PubMed ID: 31027915 [TBL] [Abstract][Full Text] [Related]
48. A comparison of ultrasound-guided three-in-one femoral nerve block versus parenteral opioids alone for analgesia in emergency department patients with hip fractures: a randomized controlled trial. Beaudoin FL; Haran JP; Liebmann O Acad Emerg Med; 2013 Jun; 20(6):584-91. PubMed ID: 23758305 [TBL] [Abstract][Full Text] [Related]
49. Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain. Chang AK; Bijur PE; Davitt M; Gallagher EJ Ann Emerg Med; 2009 Oct; 54(4):561-567.e2. PubMed ID: 19560838 [TBL] [Abstract][Full Text] [Related]
50. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty. Zuniga JR; Ibanez C; Kozacko M J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271 [TBL] [Abstract][Full Text] [Related]
51. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. Hale M; Tudor IC; Khanna S; Thipphawong J Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906 [TBL] [Abstract][Full Text] [Related]
52. Ropivacaine continuous wound infusion versus epidural morphine for postoperative analgesia after cesarean delivery: a randomized controlled trial. O'Neill P; Duarte F; Ribeiro I; Centeno MJ; Moreira J Anesth Analg; 2012 Jan; 114(1):179-85. PubMed ID: 22025490 [TBL] [Abstract][Full Text] [Related]
53. A prospective multicentre study to evaluate the efficacy and tolerability of osmotic release oral system (OROS) hydromorphone in opioid-naive cancer patients: Results of the Korean South West Oncology Group study. Song EK; Shim H; Han HS; Sun D; Lee SI; Kang MH; Lee K; Cho D; Cho IS; Park SY; Kim S; Yim CY Pain Res Manag; 2015; 20(6):293-9. PubMed ID: 26474382 [TBL] [Abstract][Full Text] [Related]
54. Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study. Wallace M; Rauck RL; Moulin D; Thipphawong J; Khanna S; Tudor IC Int J Clin Pract; 2007 Oct; 61(10):1671-6. PubMed ID: 17877652 [TBL] [Abstract][Full Text] [Related]
55. Morphine and hydromorphone epidural analgesia. A prospective, randomized comparison. Chaplan SR; Duncan SR; Brodsky JB; Brose WG Anesthesiology; 1992 Dec; 77(6):1090-4. PubMed ID: 1281625 [TBL] [Abstract][Full Text] [Related]
57. Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot study. Webster LR; Smith MD; Mackin S; Iverson M Pain Med; 2015 Mar; 16(3):460-71. PubMed ID: 25279807 [TBL] [Abstract][Full Text] [Related]
58. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction. Brogan SE; Winter NB; Okifuji A Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819 [TBL] [Abstract][Full Text] [Related]
59. A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation. Vetter TR; Carvallo D; Johnson JL; Mazurek MS; Presson RG Anesth Analg; 2007 Jun; 104(6):1356-63, table of contents. PubMed ID: 17513626 [TBL] [Abstract][Full Text] [Related]
60. The median local analgesic dose of intrathecal bupivacaine with hydromorphone for labour: a double-blind randomized controlled trial. Mhyre JM; Hong RW; Greenfield ML; Pace NL; Polley LS Can J Anaesth; 2013 Nov; 60(11):1061-9. PubMed ID: 24057426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]